{"name":"Shin Poong Pharmaceutical Co. Ltd.","slug":"shin-poong-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"shinpoong.co.kr","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Favipiravir plus Nitazoxanide","genericName":"Favipiravir plus Nitazoxanide","slug":"favipiravir-plus-nitazoxanide","indication":"Other","status":"phase_2"},{"name":"Pyramax","genericName":"Pyramax","slug":"pyramax","indication":"Other","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"SP-8203","genericName":"SP-8203","slug":"sp-8203","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"SP5M001 inj","genericName":"SP5M001 inj","slug":"sp5m001-inj","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Synovian inj","genericName":"Synovian inj","slug":"synovian-inj","indication":"Osteoarthritis of the knee","status":"phase_3"}]}],"pipeline":[{"name":"Favipiravir plus Nitazoxanide","genericName":"Favipiravir plus Nitazoxanide","slug":"favipiravir-plus-nitazoxanide","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Pyramax","genericName":"Pyramax","slug":"pyramax","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SP-8203","genericName":"SP-8203","slug":"sp-8203","phase":"phase_3","mechanism":"SP-8203 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"SP5M001 inj","genericName":"SP5M001 inj","slug":"sp5m001-inj","phase":"phase_3","mechanism":"SP5M001 inj is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes","Cardiovascular events reduction"],"catalyst":""},{"name":"Synovian inj","genericName":"Synovian inj","slug":"synovian-inj","phase":"phase_3","mechanism":"Synovian is a hyaluronic acid-based intra-articular injection that lubricates and cushions joint cartilage to reduce pain and improve mobility in osteoarthritis.","indications":["Osteoarthritis of the knee","Osteoarthritis of other joints (hip, shoulder, ankle)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2026-03-27","type":"earnings","source":"simplywall.st","summary":"The Strong Earnings Posted By Shinpoong PharmaceuticalLtd (KRX:019170) Are A Good Indication Of The Strength Of The Business - simplywall.st","headline":"The Strong Earnings Posted By Shinpoong PharmaceuticalLtd (KRX:019170) Are A Good Indication Of The Strength Of The Busi","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9JVWgwVG1LM1d2dG96czQ5SHN5aHBtNGFrTTZVbzVyNGx6b0lBNExvTVRfSTQxYmlnQVpSZ3pBNVJtSGVERkc1S2JRZzd4RFJYVWk5VG1PSlpWNzdzUEZQVGRrWEJUcTFFdkpYWjlR0gFyQVVfeXFMUDU4OUpYeEllUmF1d0JtUlZRdmd3cFpQQkk1cFR0elhTcnBob3pCOTFVcElEellhbVRwdWI0MThwVmNtckNEeHBhcVVmVGl5NTl5UXJKd24xRUpLRndFQjR2X095T3o3SVFiYkZJdDFFS3hn?oc=5","date":"2025-06-18","type":"patent","source":"koreabiomed.com","summary":"Shinpoong Pharm secures European patent for Pyramax as Covid-19 treatment - koreabiomed.com","headline":"Shinpoong Pharm secures European patent for Pyramax as Covid-19 treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1XZmpITDdSaF83cUdaa0tTdkJwS19lYlc2X0NuazFjMmcwMlFMUk5iUnphV0VYVnFXaTVHLXJUV3E4YVlrMmVyVk1FWDhSanlneFZDb2tBNVdUbVljN1k4RlZWRktmSVBQaGctc0Zn0gFyQVVfeXFMT0xOYjhocWlpRFI3QWZXMnlPOGJXTkhpS2dvbEt4RzRwX3E3OVJSUkVlQk5NUDlscTFmblZvTXRRVzZpSVdPMlJLQ3UwTnVPM1lQVHRnNWljbGpOamdmVURFZVNvZkthdmVfQmxQbVRGZXdB?oc=5","date":"2025-02-13","type":"trial","source":"koreabiomed.com","summary":"Shinpoong Pharm unveils phase 2 stroke drug data at ISC 2025 - koreabiomed.com","headline":"Shinpoong Pharm unveils phase 2 stroke drug data at ISC 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBxTFIyenlreDh4Nk1UdUNic3ZleHRueXpWaTNHWkhiaFV6c29mMzhVTkZJcVpTZElRRzBTOVd0OW5yLUE3S0xGTndadm04WEFTeGFEVlIwdElXd3pneERjUlc4Nlp2TnBmV290MDdn0gFyQVVfeXFMTjdENUM3LWZxM05CNXlNMDYzbDJJRlIycjVvc0l2bWxWSVg2UVY2NE9RZGtzOWpHU2g1VnVVS2RYdkx4R2NWdDVGWERhOWpoVnFCNnNQN3R5LXR5Q0xSZm4zaWtTM2dEeGw2Y0N3Qk9rTWZR?oc=5","date":"2024-11-14","type":"pipeline","source":"koreabiomed.com","summary":"Shinpoong chosen as optimal supplier for malaria treatments under US malaria initiative - koreabiomed.com","headline":"Shinpoong chosen as optimal supplier for malaria treatments under US malaria initiative","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQNXo0aFBncHREZTFnNUhGaUc2X202eGNnWDd4RGZTLWtkMzRSMVZ0X2Q1TVNzOGZCSzBRZ2xwdkhxVDJYODg0ODhDNzUxUExTVUk3cjE5UTJlYWNCT3BwOXRpRlJKbGNzVi1uVUpJNjlZSEsxRG54WDVqUmpyZFVFbHE3REZVa2pwOEE?oc=5","date":"2023-04-19","type":"pipeline","source":"Grand View Research","summary":"Artemisinic Acid Market Size, Share & Trends Report, 2030 - Grand View Research","headline":"Artemisinic Acid Market Size, Share & Trends Report, 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1acHN5UF8tYnBFUGhRR1dXdVluTVN1dl9HdEl3VXZnamVxUV93aHc1ZE92WXM3cWRVQllwTkRZM2c3N0p4a0ZCTjNmTW95TTBFOGFyaVhuTjVOVTBjZjFSMXEwX29RdlNSUGU3NWdB?oc=5","date":"2023-02-16","type":"pipeline","source":"KED Global","summary":"POSCO Int'l's pharmaceutical biz in Sudan attains No. 2 market ranking - KED Global","headline":"POSCO Int'l's pharmaceutical biz in Sudan attains No. 2 market ranking","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_2":1,"marketed":1,"phase_3":3},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}